HMGN5 and prostate carcinoma: Molecularly downregulation of NSBP1 resulted in decreased growth of cells and G2/M cell cycle arrest in prostate cancer [44], downregulation of Bcl-2 in ESCC [29] and downregulation of B1 cyclin in ESCC [29] and NSCLC [43].